It is worth noting that IL-9 has been shown to activate adaptive immune to suppressive tumor growth in various tumors (49), but it has a tumor-promoting effect in T cell-derived hematological cancers (50, 51). The gene discussed is IL9; the disease is hematopoietic and lymphoid cell neoplasm.